Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$206.39 - $268.73 $391,109 - $509,243
-1,895 Reduced 1.29%
145,357 $30 Million
Q1 2024

Apr 29, 2024

BUY
$203.52 - $273.43 $17.4 Million - $23.3 Million
85,300 Added 137.69%
147,252 $39.9 Million
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $15.4 Million - $22.4 Million
-93,821 Reduced 60.23%
61,952 $14.6 Million
Q3 2023

Oct 24, 2023

SELL
$194.44 - $217.61 $2.45 Million - $2.75 Million
-12,617 Reduced 7.49%
155,773 $30.5 Million
Q2 2023

Jul 31, 2023

SELL
$183.71 - $210.25 $694,240 - $794,534
-3,779 Reduced 2.19%
168,390 $35.4 Million
Q1 2023

May 10, 2023

BUY
$191.89 - $259.92 $371,882 - $503,724
1,938 Added 1.14%
172,169 $34.7 Million
Q4 2022

Feb 02, 2023

BUY
$197.11 - $250.07 $153,745 - $195,054
780 Added 0.46%
170,231 $37.1 Million
Q3 2022

Nov 09, 2022

BUY
$182.44 - $250.54 $28.9 Million - $39.7 Million
158,627 Added 1465.51%
169,451 $33.3 Million
Q2 2022

Aug 01, 2022

SELL
$204.13 - $302.4 $27,353 - $40,521
-134 Reduced 1.22%
10,824 $2.32 Million
Q1 2022

May 11, 2022

BUY
$255.51 - $362.11 $28,106 - $39,832
110 Added 1.01%
10,958 $3.11 Million
Q4 2021

Feb 09, 2022

BUY
$351.38 - $448.68 $61,842 - $78,967
176 Added 1.65%
10,848 $4.09 Million
Q3 2021

Nov 08, 2021

BUY
$372.64 - $458.3 $67,820 - $83,410
182 Added 1.73%
10,672 $4.4 Million
Q2 2021

Aug 10, 2021

BUY
$294.17 - $371.65 $167,676 - $211,840
570 Added 5.75%
10,490 $3.88 Million
Q1 2021

May 12, 2021

BUY
$249.67 - $299.48 $8,988 - $10,781
36 Added 0.36%
9,920 $2.88 Million
Q4 2020

Feb 10, 2021

BUY
$222.0 - $252.62 $242,424 - $275,861
1,092 Added 12.42%
9,884 $2.47 Million
Q3 2020

Nov 10, 2020

BUY
$175.56 - $226.45 $159,935 - $206,295
911 Added 11.56%
8,792 $1.99 Million
Q2 2020

Aug 10, 2020

BUY
$118.84 - $189.72 $936,578 - $1.5 Million
7,881 New
7,881 $1.37 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.55B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Argent Capital Management LLC Portfolio

Follow Argent Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argent Capital Management LLC with notifications on news.